Browse "HKU-Pasteur Research Centre: Conference papers" by Title

Browse
or enter initial letters to jump into index at that point:  
TitleAuthor(s)YearView Count
Antibody-Dependent Enhancement (ADE) of infection and its possible role in the pathogenesis of influenzaDutry, I; Yen, HL; Lee, H; Peiris, M; Jaume, M2011122
Antibody-Dependent Enhancement (ADE) of infection and its possible role in the pathogenesis of influenzaDutry, ICA; Yen, H; Lee, HHY; Peiris, JSM; Jaume, MDA201081
Antibody-Dependent Enhancement (ADE) of influenza infection and its possible role in the pathogenesis of influenzaDutry, I; Yen, HL; Lee, H; Peiris, M; Jaume, M2011138
Antibody-Dependent Enhancement (ADE) of influenza infection and its possible role in the pathogenesis of influenzaDutry, ICA; Yen, H; Lee, HHY; Peiris, M; Jaume, MDA201094
Antiviral activity of a selective COX-2 inhibitor NS-398 on avian influenza H5N1 infectionLee, SMY; Gai, WW; Cheung, TKW; Peiris, JSM2011320
Development of High Throughput Screening platform. Application to drug discovery and Sero-diagnosis.Garcia, J; Nefkens, I; Choi, PS; Tang, D; Zuo, JP; Nan, F; Li, J; Nal-Rogier, BTM; Peiris, JSM; Altmeyer, RM200694
Direct identification and quantification of host and viral microRNAs after influenza infection using the next generation ultra-high throughput DNA sequencer.Lee, MY; Tong, AHY; Zhang, N; Bao, Y; Lok, S201085
Evaluation of H5 pseudoparticle for serology testing in humans and animals.Garcia, J; De Jong, M; Hien, VH; Ha, DQ; Govorkova, E; Peiris, JSM200882
Evaluation of in vitro cross-reactivity with avian influenza H5N1 and swine flu H1N1 2009 viruses in healthy volunteers vaccinated with a prime boost regimen of seasonal influenza vaccineBethell, D; Jongkaewwattana, A; Kramyu, J; Thitithayanont, A; Wiboon-ut, S; Saunders, D; Yongvanitchit, K; Limsalakpetch, A; Kum-Arb, U; Uthaimongkol, N; Garcia, J; Peiris, JSM; Thomas, S; Engering, A; Jarman, R; Mongkolsirichaikul, D; Mason, C; Khemnu, N; Tyner, S; Walsh, D201076
FCGAMMARII-MEDIATED SARS-COV ENTRY IN HUMAN B CELL LINESJaume, MDA; Kien, FS; Kam, YW; Li, PH; Cheung, YC; Peiris, JSM; Daeron, M; Nal-Rogier, BTM; Altmeyer, RM2006103
FcgammaRII-mediated SARS-CoV entry in human B cell linesJaume, MDA; Kien, FS; Kam, YW; Corby, P; Li, PH; Chu, SL; Tse, KS; CHEUNG, YC; Peiris, JSM; Daeron, M; Nal-Rogier, BTM; Altmeyer, RM200693
Formation of virus-like particles from human cell lines exclusively expressing Influenza NeuraminidaseLai, JCC; Nicholls, JM; Peiris, JSM; Garcia, J2010112
H5 pseudotyped lentiviral particles: a new tool for H5N1 infection sero-diagnosisChu, S; Channa, M; Bunthin, Y; Garcia, JM; Buchy, P2009131
H5 pseudotyped lentiviral particles: a new tool for sero-diagnosis of influenza H5N1 infectionGarcia, J; Nefkens, I; Lagarde, NJC; Chu, SL; Buchy, P; Altmeyer, RM; Peiris, JSM200797
H5-type influenza hemagglutinin is functionally recognized by the natural killer activating receptor, Nkp44Ho, JWY; Hershkovitz, O; Peiris, M; Zilka, A; Bar-Ilan, A; Nal, B; Chu, K; Kudelko, M; Kam, YW; Achdout, H; Mandelboim, M; Altmeyer, R; Mandelboim, O; Bruzzone, R; Porgador, A200887
Hemagglutinin-neuraminidase balance confers respiratory droplet transmissibility of the pandemic H1N1 influenza virus in ferretsYen, H; Liang, C; Wu, C; Forrest, H; Ferguson, A; Choy, KT; Jones, J; Wong, DDY; Cheung, PHP; Hsu, C; Li, OTW; Yuen, KM; Chan, WY; Poon, LLM; Chan, MCW; Nicholls, JM; Krauss, S; Wong, CH; Guan, Y; Webster, RG; Webby, R; Peiris, JSM2011188
High Throughput Screening technological platform: Application to drug discovery, sero-diagnosis and cellular biology researchGarcia, J; Nefkens, I; Choi, PS; Lagarde, NJC; Tang, D; Zuo, JP; Nan, F; Li, J; Vanhoutte, PMGR; Nal-Rogier, BTM; Bruzzone, R; Peiris, JSM; Altmeyer, RM200694
Identification of molecular determinants for efficient H5pp productionLam, YM; Tang, D; Chu, SL; Nal-Rogier, BTM; Bruzzone, R; Lam, CHP201073
Identification of novel interactions between viral envelop proteins and activating receptor family of natural killer cellsHo, JWY; Porgador, A; Bruzzone, R2006124
Immunization with trimeric S glycoprotein protects from SARS-CoV challenge despite the presence of in vitro facilitating antibodiesKam, YW; Kien, FS; Roberts, A; Cheung, CY; Lamirande, E W; Vogel, L; Chu, SL; Chan, CM; Tse, KS; Subarao, K; Peiris, JSM; Nal-Rogier, BTM; Altmeyer, RM2005109